BAG1 and prostate carcinoma: To determine the selectivity of the Bag-1 peptide toward inhibition of prostate cancer cell growth, we overexpressed the 19-mer in a series of benign prostate cells and prostate cancer cell lines and performed clonogenic assays with these cells.